Aberrant KIF20A expression might independently predict poor overall survival and recurrence‐free survival of hepatocellular carcinoma
- 2 March 2018
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 70 (4), 328-335
- https://doi.org/10.1002/iub.1726
Abstract
Kinesin family member 20A (KIF20A) is an essential regulator of cytokinesis. In this study, by performing a retrospective study based on data from the Cancer Genome Atlas (TCGA)–Liver and Hepatocellular Carcinoma (LIHC) cohort, we tried to assess the independent prognostic value of KIF20A in terms of overall survival (OS) and recurrence-free survival (RFS). Results showed that normal liver tissues had very low KIF20A expression compared with normal tissues in other cohorts in TCGA. However, the primary HCC tissues (N = 371) had significantly elevated KIF20A expression than normal liver tissues (N = 50). Immunohistochemistry (IHC) data showed that normal hepatocytes had weak KIF20A staining. In comparison, some HCC tissues had medium and strong KIF20A expression, with nuclear-enhanced staining. By grouping patients with primary HCC (N = 365) into high and low KIF20A expression groups, we found that the high expression group had a substantially higher proportion of high-grade tumors (G3/G4) (34/65, 52.3% vs. 96/295, 32.5%, P = 0.0027), advanced tumors (stage III/IV) (28/61, 45.9% vs. 59/280, 21.1%, P < 0.0001) and death (44/67, 65.7% vs. 86/298, 28.9%, P < 0.0001) compared with the low expression group. Kaplan-Meier curves of OS and RFS indicated that high KIF20A expression was associated with worse survival outcomes. Subgroup analysis confirmed the associations in G1/G2, G3/G4 tumors and in early and advanced stages. Following univariate and multivariate analysis revealed that KIF20A expression was an independent prognostic indicator for poor OS (HR: 1.304, 95%CI: 1.157–1.469, P < 0.001) and RFS (HR: 1.144, 95%CI: 1.028–1.272, P < 0.001). Based on these findings, we infer that KIF20A was aberrantly expressed in HCC tissues and its expression might independently predict poor OS and RFS. © 2018 IUBMB Life, 2018Keywords
This publication has 27 references indexed in Scilit:
- Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 PatientsPLOS ONE, 2017
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistanceOncogene, 2015
- KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer CellsNeoplasia, 2014
- Kinesins and cancerNature Reviews Cancer, 2012
- Deregulation of Rab and Rab Effector Genes in Bladder CancerPLOS ONE, 2012
- Walking the walk: how kinesin and dynein coordinate their stepsCurrent Opinion in Cell Biology, 2009
- Loss of the Forkhead Transcription Factor FoxM1 Causes Centrosome Amplification and Mitotic CatastropheCancer Research, 2005
- Dynein and kinesin share an overlapping microtubule-binding siteThe EMBO Journal, 2004
- The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesisThe EMBO Journal, 2000
- Interaction of a Golgi-Associated Kinesin-Like Protein with Rab6Science, 1998